Literature DB >> 9650018

Intestinal epithelial hyperpermeability. Mechanisms and relevance to disease.

N Unno1, M P Fink.   

Abstract

Pathologic increases in intestinal permeability to hydrophilic macromolecules has been identified in a number of clinical conditions. The significance of gut barrier dysfunction as a clinical issue remains to be delineated, although it seems likely that alterations in intestinal epithelial permeability play a causative role in a number of conditions ranging from inflammatory bowel disease to the development of complications after cardiopulmonary bypass. It is unlikely that any one mechanism can account for all cases of intestinal hyperpermeability. Rather, it is more probable that myriad factors or combinations of factors, including mesenteric ischemia and cytokine-induced phenomena, lead to alterations in permeability in different clinical entities. Nevertheless, from a purely mechanistic standpoint, some common themes, notably the role of ATP depletion, increases in [Ca2+]i, and cytoskeletal derangements in enterocytes, have emerged as being particularly important.

Entities:  

Mesh:

Year:  1998        PMID: 9650018     DOI: 10.1016/s0889-8553(05)70004-2

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

1.  Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis.

Authors:  Nicolas T Schwarz; Donna Beer-Stolz; Richard L Simmons; Anthony J Bauer
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patients.

Authors:  Mitchell P Fink
Journal:  Intensive Care Med       Date:  2002-01-12       Impact factor: 17.440

3.  Comparative tight junction protein expressions in colonic Crohn's disease, ulcerative colitis, and tuberculosis: a new perspective.

Authors:  Prasenjit Das; Pooja Goswami; Tapash K Das; Tapas Nag; Vishnubhatla Sreenivas; Vineet Ahuja; Subrat K Panda; Siddhartha Datta Gupta; Govind K Makharia
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

4.  Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.

Authors:  A Alhamoruni; K L Wright; M Larvin; S E O'Sullivan
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Hypogammaglobulinaemia secondary to cow-milk allergy in children under 2 years of age.

Authors:  Liliana Bezrodnik; Andrea C Gómez Raccio; Laura M Canil; Maria Amanda Rey; Patricia C Carabajal; Carlos A Fossati; Guillermo H Docena
Journal:  Immunology       Date:  2007-05-11       Impact factor: 7.397

6.  Discrepancies between the responses to skin prick test to food and respiratory antigens in two subtypes of patients with irritable bowel syndrome.

Authors:  Rosa-Ls Soares; Hamilton-N Figueiredo; Jose-M Santos; Rita-F Oliveira; Raquel-L Godoy; Felipe-Ap Mendonca
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

7.  Kinetic analysis of 5 sugar probes in dog serum after orogastric administration.

Authors:  Heriberto Rodríguez; Nora Berghoff; Jan S Suchodolski; Jörg M Steiner
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

8.  Increased paracellular permeability of tumor-adjacent areas in 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.

Authors:  Viktoria V Bekusova; Evgeny L Falchuk; Larisa S Okorokova; Natalia M Kruglova; Alexander D Nozdrachev; Alexander G Markov
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

9.  Pyk2 inhibitor prevents epithelial hyperpermeability induced by HMGB1 and inflammatory cytokines in Caco-2 cells.

Authors:  Takumi Konno; Takayuki Kohno; Maki Miyakawa; Hiroki Tanaka; Takashi Kojima
Journal:  Tissue Barriers       Date:  2021-03-04

10.  Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.

Authors:  G T Furuta; J R Turner; C T Taylor; R M Hershberg; K Comerford; S Narravula; D K Podolsky; S P Colgan
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.